Search research articles
Contact Us
Filters
Showing results (161-170 of 283) with videos related to
Page
of 29
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 30, 2017
Lack of a Prognostic Impact of the MyD88 L265P Mutation for Diffuse Large B Cell Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
Yi-Shan Lee, Jingxia Liu, Kristine A Fricano, et al.
Journal of Translational Medicine
|
February 2, 2015
Personalization of cancer treatment using predictive simulation
Nicole A Doudican, Ansu Kumar, Neeraj Kumar Singh, et al.
Annals of Hematology
|
August 3, 2017
Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study
Artur Jurczyszyn, Alessandro Gozzetti, Joanna Gdula-Argasińska, et al.
Leukemia
|
May 16, 2020
A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma
Joseph Mikhael, Joshua Richter, Ravi Vij, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 23, 2020
VLA4-Targeted Nanoparticles Hijack Cell Adhesion-Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival
Francesca Fontana, Michael J Scott, John S Allen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 27, 2022
A Phase I First-in-Human Study of ABBV-383, a B-Cell Maturation Antigen × CD3 Bispecific T-Cell Redirecting Antibody, in Patients With Relapsed/Refractory Multiple Myeloma
Anita D'Souza, Nina Shah, Cesar Rodriguez, et al.
Iscience
|
January 23, 2025
Germline predisposition in multiple myeloma
Fernanda Martins Rodrigues, Jagoda Jasielec, Melody Perpich, et al.
Plos One
|
May 29, 2015
Whole Genome Sequence of Multiple Myeloma-Prone C57BL/KaLwRij Mouse Strain Suggests the Origin of Disease Involves Multiple Cell Types
Sarah R Amend, William C Wilson, Liang Chu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 25, 2022
First-in-Humans Evaluation of Safety and Dosimetry of <sup>64</sup>Cu-LLP2A for PET Imaging
Richard Laforest, Anchal Ghai, Tyler J Fraum, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 15, 2013
Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimen
Shivaprasad Manjappa, Pavan Kumar Bhamidipati, Keith E Stokerl-Goldstein, et al.
Page
of 29
Search research articles
Search
Showing results (161-170 of 283) with videos related to
Sort By:
Page
of 29
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 30, 2017
Lack of a Prognostic Impact of the MyD88 L265P Mutation for Diffuse Large B Cell Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
Yi-Shan Lee, Jingxia Liu, Kristine A Fricano, et al.
Journal of Translational Medicine
|
February 2, 2015
Personalization of cancer treatment using predictive simulation
Nicole A Doudican, Ansu Kumar, Neeraj Kumar Singh, et al.
Annals of Hematology
|
August 3, 2017
Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study
Artur Jurczyszyn, Alessandro Gozzetti, Joanna Gdula-Argasińska, et al.
Leukemia
|
May 16, 2020
A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma
Joseph Mikhael, Joshua Richter, Ravi Vij, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 23, 2020
VLA4-Targeted Nanoparticles Hijack Cell Adhesion-Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival
Francesca Fontana, Michael J Scott, John S Allen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 27, 2022
A Phase I First-in-Human Study of ABBV-383, a B-Cell Maturation Antigen × CD3 Bispecific T-Cell Redirecting Antibody, in Patients With Relapsed/Refractory Multiple Myeloma
Anita D'Souza, Nina Shah, Cesar Rodriguez, et al.
Iscience
|
January 23, 2025
Germline predisposition in multiple myeloma
Fernanda Martins Rodrigues, Jagoda Jasielec, Melody Perpich, et al.
Plos One
|
May 29, 2015
Whole Genome Sequence of Multiple Myeloma-Prone C57BL/KaLwRij Mouse Strain Suggests the Origin of Disease Involves Multiple Cell Types
Sarah R Amend, William C Wilson, Liang Chu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 25, 2022
First-in-Humans Evaluation of Safety and Dosimetry of <sup>64</sup>Cu-LLP2A for PET Imaging
Richard Laforest, Anchal Ghai, Tyler J Fraum, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 15, 2013
Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimen
Shivaprasad Manjappa, Pavan Kumar Bhamidipati, Keith E Stokerl-Goldstein, et al.
Page
of 29